Japan · Series B startup
3 rounds we have observed, with the 7 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Raised 1 month ago
Follow Celaid Therapeutics and see its new rounds in your feed. Start following
Funding summaryUpdated 7 Nov 2026
$13Mraised across 3 rounds since 2025, from 3 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Road CapitalLeadReported by TechStartups
From Celaid Therapeutics's own website: 2 on the team.
AdvisersLee Buckler
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Road CapitalLMissing a round, or an investor who was in one? Tell us.
Celaid Therapeutics's investors include Road Capital, Galaxy Ventures, SBI Group, Venture capital firms and Japan's AMED (Japan Agency for Medical Research and Development), and 2 more on record.
Celaid Therapeutics has raised $13M across 3 rounds since 2025.
Celaid Therapeutics's most recent round was a Series B of $2.5M in Oct 2026.
Celaid Therapeutics's largest round on record is $7.2M (Series B), in Oct 2025, led by Road Capital.
Celaid Therapeutics's first round on record, in Oct 2025, was backed by SBI Group.
Celaid Therapeutics's latest named round is a Series B, in Oct 2026.
Celaid Therapeutics is based in Japan.
Road Capital led the Series B in 2025.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
Japan · 
